NCT05901831: An ongoing trial by Bayer
This trial is ongoing. It must report results 1 year, 3 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05901831 |
|---|---|
| Title | A Parallel-group, Randomized, Prospective, Interventional, Double-blind, Multicenter Global Phase 3 Study to Investigate the Efficacy and Safety of Finerenone Versus Placebo, in Addition to Standard of Care, in Participants With Chronic Kidney Disease and Type 1 Diabetes |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 26, 2024 |
| Completion date | Aug. 22, 2025 |
| Required reporting date | Aug. 22, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | May 22, 2025 |
| Days late | None |